688253 fundamentals

Innovita Biological Technology Co., Ltd. engages in the research and development, production, and sale of point-of-care testing rapid diagnostic products. It offers five-in-one whole blood respiratory pathogen Immunoglobulin M, three-in-one combined testing of influenza Immunoglobulin M, and five-in-one combined testing of serum respiratory viruses Immunoglobulin M. It also provides prenatal and postnatal care testing products, automatic colloidal gold immunochromatography analyzers, and automatic blood cell analysis pre-sample processors. The company was founded by Xiu Jie Zhang on February 6, 2006 and is headquartered in Beijing, China.